Andrea Pellagatti

11PUBLICATIONS
78CO-AUTHORS
Molecular medicineMedical mycologyMedical virologyRegenerative medicine (incl. stem cells)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 24, 2025
Identification of new candidate drugs in myelodysplastic syndromes with splicing factor mutations by transcriptional profiling and connectivity map analysis.

Tianyu Sun, Shalini Singh, Hayson Chenyu Wang

|Jul 03, 2024
Molecular taxonomy of myelodysplastic syndromes and its clinical implications.

Elsa Bernard, Robert P Hasserjian, Peter L Greenberg

|Apr 30, 2024
Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes.

Maria Sirenko, Elsa Bernard, Maria Creignou

|Oct 13, 2021
BCL-2 Inhibitor ABT-737 Effectively Targets Leukemia-Initiating Cells with Differential Regulation of Relevant Genes Leading to Extended Survival in a NRAS/BCL-2 Mouse Model of High Risk-Myelodysplastic Syndrome.

Petra Gorombei, Fabien Guidez, Saravanan Ganesan

|Sep 22, 2021
ASXL1 mutations are associated with distinct epigenomic alterations that lead to sensitivity to venetoclax and azacytidine.

Nora E Rahmani, Nandini Ramachandra, Srabani Sahu

|Feb 21, 2020
SF3B1 mutations induce R-loop accumulation and DNA damage in MDS and leukemia cells with therapeutic implications.

Shalini Singh, Doaa Ahmed, Hamid Dolatshad

Pageof 2

Frequent Collaborators

7 joint publications

Jacqueline Boultwood

3 joint publications

Luca Malcovati

3 joint publications

Michael R Savona

2 joint publications

Maria Sirenko